Experiments were designed to determine whether a heterogeneity of endothelium-dependent relaxations in arteries from different vascular beds exists in experimental congestive heart failure (CHF) and to determine the mediators of those responses. CHF was produced in dogs by rapid ventricular pacing for 15 d. Rings of coronary, femoral, and renal arteries with and without endothelium from control and CHF dogs were suspended in organ chambers for measurement of isometric force. In arteries contracted with prostaglandin F2 alpha, endothelium-dependent relaxations to BHT 920 (an alpha2-adrenergic agonist) were increased in coronary arteries from dogs with CHF (maximal relaxation: control -15±9% vs CHF -92±5%; n = 5-6; P < 0.05), with a modest enhancement in renal arteries. Relaxations to adenosine diphosphate and the calcium ionophore were unchanged. Relaxations to BHT 920 in CHF were reduced by NG monomethyl-L-arginine (L-NMMA) and pertussis toxin but not by indomethacin. These data suggest that endothelium-dependent relaxations are affected heterogeneously in CHF. The enhanced response to alpha2-adrenergic agonists in the coronary artery is mediated by nitric oxide through a mechanism sensitive to inhibition by pertussis toxin. This selective increase in endothelium-dependent relaxations in the coronary artery may contribute to preserving coronary blood flow during CHF. (J. Clin. Invest. 1994. 93:165-171.) 
Introduction
While systemic vasoconstriction is a hallmark ofsevere chronic congestive heart failure (CHF),' a preservation of coronary blood flow has been reported both in human and in experimental CHF (1) (2) (3) (4) . The role of endothelium in contributing to altered vascular responses in CHF, however, remains controversial (5) (6) (7) (8) (9) . Recent studies have suggested that enhanced endothelium-dependent relaxations to alpha2-adrenergic agonists in experimental CHF may serve as an important protective mechanism to maintain coronary blood flow (9) . Specifically, recent investigations which examined alpha-adrenergic responses in isolated coronary arterial rings from dogs with and without pacing-induced CHF demonstrated an augmentation of endothelium-dependent relaxation to norepinephrine and the alpha2-adrenoreceptor agonist 6-allyl-2-amino-5,6,7,8-tetrahydro-4H-thiazolo-(4,5-d)azepin hydrochloride (BHT 920), thus supporting a role for increased endothelium-dependent vasodilatory mechanisms in regulating the coronary circulation in CHF.
The current investigation was designed to extend these previous studies and to determine if enhancement of endothelium-dependent relaxations in vitro in experimental CHF is specific to the coronary circulation, and secondly, to determine if endothelium-dependent relaxations in the coronary circulation are altered to other agonists. Thirdly, we sought to elucidate the mechanism underlying the enhanced alpha2-adrenergic endothelium-dependent relaxations, testing the hypothesis that this augmented coronary vascular response is mediated by nitric oxide (NO) and involves a guanine nucleotide-binding regulatory protein (G-protein) mechanism.
Methods
Experiments were performed in two groups of mongrel dogs (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) kg) that were fed standard diet and allowed free access to water. Dogs that had not been operated on served as the control group. To produce experimental CHF, dogs underwent rapid ventricular pacing for 15 d. This time period of pacing consistently produces a hemodynamic and neurohumoral state of severe CHF (10) .
Model of experimental CHF. Dogs in the CHF group underwent implantation ofa permanent pacemaker 5 d before the onset ofpacing.
Under pentobarbital anesthesia (30 mg/kg intravenously [iv] ), a left thoracotomy incision was made at the fourth intercostal space, the heart was exposed, the pericardium was opened, and a screw-in epicardial pacemaker lead was attached to the right ventricular myocardium. The pacemaker lead was connected to a generator implanted subcutaneously (5320; Medtronic Inc., Minneapolis, MN). The say was collected into EDTA tubes and was placed on ice immediately. After centrifugation at 2,500 rpm at 4VC for 10 min, the plasma was separated and stored at -20'C until assay. Atrial natriuretic factor (ANF) was determined after extraction by RIA as previously described (11) . Plasma renin activity (PRA) was determined by RIA as reported previously (12) . At this point, the dogs were exsanguinated through the carotid artery. Control dogs received pentobarbital sodium (30 mg/kg iv) and were exsanguinated through the carotid artery. In vitro experiment. The heart, renal, and femoral arteries were removed and placed in a chilled, modified Krebs-Ringer bicarbonate solution (control solution) of the following composition (mM): NaCl 118.3, KCl 4.7, CaCl2 2.5, MgSO4 1.2, KH2PO4 1.2, NaHCO3 25.0, CaEDTA 0.026, and glucose 11.1. The left circumflex coronary artery was dissected from the heart. Then the arteries were cleaned ofconnective tissue, with care taken not to touch the luminal surface, and were cut into rings 5 mm in length. Some rings were denuded of endothelium by inserting a pair of fine forceps into the lumen and gently rolling the ring back and forth on Krebs-Ringer-wetted paper. Rings of coronary, femoral, and renal arteries, with and without endothelium, from a single dog were studied in parallel. Each ring was mounted between a fixed point and a force transducer (UC-2; Gould Inc., Glen Bournie, MD) for measurement of isometric force (model 7418A recorder; Hewlett-Packard Co., Palo Alto, CA) in an organ bath filled with 25 ml of the buffered salt solution at 370C and was gassed with 95% 02-5% CO2. Each ring was progressively stretched to the optimal point on its length-tension curve, as determined by the active tension developed to potassium chloride 20 mM.
After a 30-min equilibration period, a cumulative concentrationresponse curve to PGF2alpha (I0-8-I0-5 M) was obtained. To study endothelium-dependent relaxations, the vessels were then contracted with PGF2alpha (2 x 10-6 M). Relaxations were studied in one oftwo separate sequences: acetylcholine, calcium ionophore A23187, and nitric oxide; or BHT 920 (13) , and ADP. After each cumulative concentration-response curve, the tissues were washed at least three times with the control solution, and at least 30 min were allowed to elapse before the next drug was used.
To study the mechanism of enhanced endothelium-dependent relaxation to alpha2-adrenergic stimulation in coronary arteries, relaxations to BHT 920 and A23187 were tested in either the absence or presence of indomethacin (l0-' M, 60 min) alone, indomethacin Drugs. The following drugs were used: acetylcholine, adenosine diphosphate, calcium ionophore A23187, indomethacin, pertussis toxin, PGF2alpha (Sigma Chemical Co., St. Louis, MO), BHT 920 (Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT), and L-NMMA (Calbiochem-Novabiochem Corp., La Jolla, CA). Drugs were prepared daily in distilled water and were kept refrigerated at 40C until use. Concentrations ofthe drugs are reported as the final molar concentration in the organ bath.
Preparation of nitric oxide. A gas bulb fitted with a silicon rubber injection septum was filled with NO from a cylinder (Union Carbide, Chicago, IL). An appropriate volume (10-1,000 ,l) was removed with a syringe and was injected into another gas bulb filled with 100 ml of distilled water, which had been gassed with helium for 3 h, giving stock solutions of NO of 4 X IO -5 M and 4 X 10-4 M.
Statistical analysis. In the in vitro experiments, n equals the number of rings taken from different dogs. The results are expressed as means±SEM. When rings with and without endothelium from a single dog were tested in parallel, Student's t test for paired observations was used. When responses from different dogs were compared, an analysis of variance for one-way classification was used. Where appropriate, the effective concentration required to produce 10 or 50% of a maximal response (ED10, ED50) was calculated for the individual concentration-response curves, and the mean of these values is reported as the negative log of the molar concentration. Values were considered to be statistically significant when P < 0.05.
Results

HEMODYNAMIC AND HORMONAL PARAMETERS
The hemodynamic parameters and hormonal values from the CHF group are compared to a control group in Table I . MAP and CO were significantly reduced in CHF in association with characteristic elevations in left and right atrial filling pressures. Calculated SVR was increased in CHF and elevation of circulating ANF and PRA occurred.
GENERAL RESPONSIVENESS OF VESSELS
There were no differences between groups in the resting tension of coronary or renal arteries, with or without endothelium, at the optimal point on their length-tension curve (Table II) . However, femoral arteries with endothelium had a lower resting tension in CHF compared with control. In CHF, ED50 for PGF2alpha ofarteries with endothelium were similar to control values for that artery (Table III) ; removal of the endothelium resulted in a small but statistically significant increase in sensitivity to this agonist. Maximal tension developed to PGF2alpha (Table III) did not differ in CHF compared with control.
Endothelium-dependent responses
ACETYLCHOLINE
In all arteries, acetylcholine produced concentration-dependent relaxations of rings with endothelium ( Fig. 1 , A-C). In coronary arteries ( Fig. 1 A) , the threshold for relaxation occurred at significantly lower concentrations during CHF compared with control (-log ED-10: control 8.3±0.1 vs CHF 8.7±0.1; n = 6, P < 0.05). CHF did not significantly alter the responses of femoral or renal arteries (Fig. 1 , B and C) from those seen in control vessels. Without endothelium. In each artery studied, when the endothelium was removed BHT produced a contraction which did not differ in CHF from control ( Figs. 2 and 3 ; femoral data not shown).
Adenosine diphosphate ADP produced concentration-dependent relaxations of all arteries, which were greater in rings with endothelium than in rings without endothelium. When relaxations to ADP ofarteries with endothelium (Table IV) (Table IV) . 
Nitric oxide
Relaxations to the endothelium-derived relaxing factor nitric oxide were tested in rings from which the endothelium had been removed (Fig. 4, A-C In both control (Fig. 5 A) and CHF (Fig. 5 B) rings, resting tension of coronary arteries with endothelium increased slightly after indomethacin. In control rings (Fig. 5 A) , the addition of L-NMMA produced a further increase in resting tension to a level not significantly greater than after indomethacin alone. In CHF (Fig. 5 B) , however, resting tension after L-NMMA and indomethacin significantly exceeded that seen with indomethacin alone. Indomethacin significantly increased the resting tension of both control (Fig. 6 A) and CHF ( Fig. 6 B) BHT 920
In control arteries, indomethacin did not significantly reduce relaxations to BHT 920. However, indomethacin in combination with either pertussis toxin or L-NMMA eliminated the relaxations to this agonist (Fig. 7 A) . During CHF, indomethacin did not significantly reduce endothelium-dependent relaxations ofcoronary arteries to BHT 920 (Fig. 7 B) . The addition of L-NMMA, however, reduced the maximal relaxation from -86±7% (no inhibitor) to -15±4% (indomethacin plus L-NMMA) (P < 0.05). Similarly, the addition of pertussis toxin almost abolished the response: -86±7% (no inhibitor) vs -7±5% (indomethacin plus pertussis toxin, P < 0.05). Re- . Vessels were contracted with PGF2 alpha (2 x 106; for each artery, contractions to PGF2 alpha did not differ between experimental groups). * P < 0.05 vs no inhibitor; t P < 0.05 vs indomethacin; § P < 0.05 vs indomethacin/pertussis toxin; 1 1 P < 0.05 vs control. n = 6 in all groups.
sponses to BHT 920 in arteries without endothelium were not altered (data not shown).
A23187
Non-receptor-mediated endothelium-dependent relaxations in control and CHF coronary arteries are shown in Table V . Within both groups, the addition of indomethacin with or without pertussis toxin did not alter the sensitivity of coronary arteries to A23 187. L-NMMA produced a significant shift to the right in the concentration-response curve to the calcium ionophore in both groups which, however, was less in CHF than in control.
Discussion
The major finding of this study is that endothelium-dependent relaxations are affected heterogeneously in CHF. Specifically, alpha2-adrenergic pathways of endothelium-dependent relaxation are enhanced in the coronary circulation, and to a lesser magnitude in the renal circulation, while other mechanisms are essentially unchanged. This enhancement is mediated by increased production of nitric oxide through a pertussis toxinsensitive pathway.
In human and experimental congestive heart failure, optimal circulatory homeostasis is achieved by a delicate balance of vasoconstrictor and vasodilator mechanisms. Activation ofcatecholamines ( 14) , the renin-angiotensin-aldosterone system ( 15), vasopressin ( 16) , and endothelin ( 17) promote vasoconstriction which is balanced by endogenous vasodilator forces such as prostaglandin ( 18) and atrial and brain natriuretic peptides ( 1 1, 19) . In severe CHF, vasoconstrictor mechanisms predominate with elevation ofsystemic vascular resistance in association with renal, splanchnic, and cutaneous vasoconstriction (1, 20) and impaired peripheral vasodilation (21) . However, coronary blood flow is preserved ( 1-4) and coronary vascular resistance may be reduced (2, 4) . The results ofour study demonstrate that enhancement of a local vasodilator mechanism, namely alpha2-adrenergic receptor-mediated endothelium-dependent relaxation, occurs in the coronary but not femoral artery in experimental CHF. Thus, this alteration of local endogenous vasodilator forces may, in a milieu of elevated circulating catecholamines ( 14) , contribute to the preservation of .p 7- coronary blood flow in CHF, as suggested by Main and coworkers (9) . In addition, such vasodilatory mechanisms may also serve to preserve renal blood flow in CHF.
In this investigation and in that of Main et al. (9) , endothelial responses were studied only in large epicardial conduit arteries and not resistance vessels. Therefore, caution should be exercised in extrapolating the results to the regulation of coronary blood flow by the coronary microcirculation. Secondly, differential regulation of large conduit arteries as compared with the microcirculation may occur in CHF, as noted in the preliminary studies of Bank et al. (22) , which demonstrated an intact endothelial response in large arteries of the human forearm as compared with an impaired response in the microcirculation. Differences in endothelium-dependent relaxations between arteries from control and CHF animals are probably not due to differences in contractions to PGF2alpha as these were similar from both groups of dogs. Decreased sensitivity to the prostanoid in coronary arteries with endothelium may be due to basal release of endothelium-derived relaxing factor.
Using acetylcholine, a depression of endothelium-dependent relaxation in CHF has been demonstrated in both human and animal models of CHF (5) (6) (7) (8) (23) (24) (25) . The present study examined responses to acetylcholine after 2 wk ofexperimental CHF and found that the threshold for relaxation to acetylcholine was decreased significantly in coronary arteries but was unchanged in femoral and renal arteries. Increases in blood flow in canine systemic arteries result in augmented endothelium-dependent relaxations to acetylcholine (26) and studies, while controversial (2, 27) , have demonstrated increased myocardial blood flow in CHF. A similar mechanism may operate to produce the augmented response to acetylcholine reported in this study. Additionally, an endothelium-derived hyperpolarizing factor (28) may be altered during CHF, but this mechanism was not evaluated in our study.
In contrast to the enhancement of responses to alpha2-adrenergic and muscarinic receptor stimulation seen in coronary arteries, endothelium-dependent relaxations to adenosine diphosphate, mediated by endothelial purinergic (P2) receptors (29, 30) and the calcium ionophore A23187, which increases endothelial cytosolic calcium independently of receptors, were unchanged in CHF. In addition, responses offemoral and renal arteries to these agonists did not differ in CHF from control. Thus, the enhancement ofendothelial vasodilator function appears to occur in association with specific pathways while others are unchanged. It is a significant negative finding that these responses were not impaired and provides further evidence against a generalized dysfunction of endothelium-dependent responses in experimental CHF.
The sensitivity ofcoronary and renal vascular smooth muscle to the major chemical form of endothelium-derived relaxing factor, namely NO (31 ), was unchanged during CHF. However, the tendency for a reduced sensitivity to NO seen in femoral arterial smooth muscle may play a role in regional vascular tone favoring the maintenance of coronary as opposed to peripheral blood flow. Such an impaired femoral vasodilator response in CHF is at variance with the observations of Kaiser et al. (25) , which may, in part, be explained by differences in experimental preparation. It should also be noted that a decreased resting tension was noted in the femoral arteries in CHF. The mechanism of this is unclear but, in part, could be explained by the use of the anesthetic agents.
Neither maximal relaxation to BHT 920 nor resting tension were altered in the presence ofindomethacin. While many substances stimulate the production and release of endothelial vasodilator prostanoids ( 18) , it does not appear from this study that such a pathway is involved in the exaggerated response to alpha2 stimulation of coronary arteries seen in CHF. The addition of L-NMMA to coronary arteries with endothelium resulted in increased resting tension, a difference which was greater in CHF than in control. This suggests that tonic release of NO may be increased in CHF. In contrast, while the data support basal production of inhibitory prostanoids in denuded smooth muscle, they do not support the induction of NO synthesis in coronary smooth muscle during CHF.
In the presence of L-NMMA, the enhanced endotheliumdependent relaxations to BHT 920 seen in CHF were markedly reduced. Since the sensitivity to exogenously administered NO is not altered, these data demonstrate that enhanced stimulated release ofNO is central to the mechanism ofenhanced endothelium-dependent relaxations to alpha2-adrenergic stimulation in coronary arteries in CHF.
Alpha2 and beta adrenoreceptors are closely coupled to adenylate cyclase (32, 33) by G-proteins which inhibit (Gi) or stimulate (Gs) the catalytic unit, respectively. Responses to beta-adrenergic agonists are diminished in human CHF (34) , and while receptor downregulation occurs (35, 36) , a defect in receptor-adenylate cyclase production of cAMP also occurs (37). Feldman et al. (38) found an increased level and functional activity of Gi in failing myocardium and suggested that receptor traffic through beta receptors coupled to Gi may be inhibited during CHF.
Alpha2 receptor activation is closely coupled to Gi (32) and produces endothelium-dependent relaxation of canine coronary arteries to epinephrine and norepinephrine (39, 40) . The exotoxin pertussis toxin produces ADP ribosylation and inactivation ofGi. Previous studies have demonstrated that pertussis toxin inhibits endothelium-dependent relaxation to alpha2-adrenergic stimulation in porcine coronary arteries (41). In this study, the markedly enhanced endothelium-dependent relaxations of coronary arteries produced by the alpha2-agonist BHT 920 in CHF were completely lost in the presence of pertussis toxin. In contrast, non-receptor-mediated, endotheliumdependent relaxations, as assessed by the response to A23 187, were unchanged. These findings are analagous to those of Feldman et al. (38) with beta receptor-coupled Gi activity and suggest that a parallel increase in Gi functional activity coupled to alpha2 receptors may occur in canine coronary endothelium in CHF.
In conclusion, these studies demonstrate a selective enhancement of endothelium-dependent relaxations to alpha2-adrenergic receptor stimulation in canine coronary arteries in experimental CHF. This is not observed in femoral arteries and is only modestly seen in renal arteries. Significant changes in other mechanisms of endothelium-dependent relaxation were not observed, and vascular smooth muscle sensitivity to NO was not altered. The mechanism of this uniquely enhanced response may involve increased stimulated production of nitric oxide. Furthermore, it may operate through a pertussis toxinsensitive pathway and may reflect increased functional activity of endothelial alpha2 receptor-associated Gi. These alterations of endothelial vasodilator function may represent an important homeostatic mechanism which, in the face of falling cardiac output, selectively contributes to the preservation ofcoronary blood flow. 
